IRIS
PUCCETTI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.719
EU - Europa 7.757
AS - Asia 4.228
SA - Sud America 671
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 123
OC - Oceania 10
Totale 22.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.552
CN - Cina 1.546
GB - Regno Unito 1.511
RU - Federazione Russa 1.491
IT - Italia 1.395
SG - Singapore 1.316
IE - Irlanda 960
UA - Ucraina 592
SE - Svezia 568
BR - Brasile 541
FR - Francia 482
DE - Germania 333
HK - Hong Kong 324
VN - Vietnam 309
KR - Corea 226
FI - Finlandia 204
BD - Bangladesh 114
IN - India 93
CA - Canada 87
ZA - Sudafrica 66
TR - Turchia 52
NL - Olanda 42
MX - Messico 41
JP - Giappone 39
IQ - Iraq 38
AR - Argentina 32
ES - Italia 28
PL - Polonia 26
BE - Belgio 25
NG - Nigeria 25
CO - Colombia 24
EC - Ecuador 22
MY - Malesia 21
PK - Pakistan 19
ID - Indonesia 18
SA - Arabia Saudita 18
AT - Austria 17
CZ - Repubblica Ceca 16
VE - Venezuela 16
KE - Kenya 13
MA - Marocco 13
UZ - Uzbekistan 11
PH - Filippine 10
AU - Australia 9
CL - Cile 9
LT - Lituania 9
CH - Svizzera 8
PY - Paraguay 8
RO - Romania 8
BO - Bolivia 7
ET - Etiopia 7
JM - Giamaica 7
PE - Perù 7
IL - Israele 6
KG - Kirghizistan 6
KZ - Kazakistan 6
NI - Nicaragua 6
OM - Oman 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DZ - Algeria 5
EU - Europa 5
HR - Croazia 5
JO - Giordania 5
NP - Nepal 5
PT - Portogallo 5
TH - Thailandia 5
DO - Repubblica Dominicana 4
HN - Honduras 4
IR - Iran 4
UY - Uruguay 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
EG - Egitto 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CR - Costa Rica 2
CY - Cipro 2
GR - Grecia 2
GT - Guatemala 2
IM - Isola di Man 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BY - Bielorussia 1
CM - Camerun 1
Totale 22.511
Salva come PNG Salva come JPEG
Città #
Southend 1.305
Dallas 1.230
Dublin 959
Fairfield 842
Singapore 770
Ashburn 683
Santa Clara 490
San Jose 485
Chandler 469
Jacksonville 466
Woodbridge 396
Moscow 375
Milan 373
Beijing 349
Wilmington 344
Houston 334
Seattle 317
Hong Kong 314
Hefei 301
Cambridge 248
Seoul 224
Ann Arbor 223
Council Bluffs 216
Princeton 191
New York 190
Nanjing 176
The Dalles 143
Siena 129
Los Angeles 123
Rome 112
Lauterbourg 100
Ho Chi Minh City 93
Hanoi 82
Helsinki 78
San Mateo 77
Shanghai 72
Buffalo 71
Boardman 65
Munich 64
Florence 60
San Diego 60
Columbus 56
Johannesburg 56
São Paulo 51
Nanchang 41
Hebei 37
Bengaluru 35
Chicago 35
Tokyo 35
Changsha 34
Toronto 33
Figino 32
Menlo Park 31
Turin 31
Turku 30
Orem 29
Lancaster 28
London 28
San Francisco 27
Shenyang 26
Brooklyn 25
Jiaxing 25
Dearborn 24
Tianjin 23
Brussels 22
Abuja 21
Boston 20
Nuremberg 19
Naples 18
Philadelphia 18
Denver 17
Frankfurt am Main 17
Hangzhou 17
Kunming 17
Warsaw 17
Düsseldorf 16
Guangzhou 16
Phoenix 16
Rio de Janeiro 16
Atlanta 15
Da Nang 15
Washington 15
Chennai 14
Haiphong 14
Istanbul 14
Jinan 14
Montreal 14
Manchester 13
Mexico City 13
Málaga 13
Ningbo 13
Baghdad 12
Bologna 12
Brasília 12
Brno 12
Norwalk 12
Stockholm 12
Belo Horizonte 11
Grosseto 11
Izmir 11
Totale 14.910
Salva come PNG Salva come JPEG
Nome #
Endogenous thrombin potential and screening parameters of coagulation [Potenziale endogeno di trombina e parametri di screening della coagulazione] 446
Potenziale endogeno di trombina (ETP) e parametri di screening della coagulazione. Comparazione tra INR, D-Dimero ed ETP in una popolazione di soggetti anticoagulati con Warfarin per fibrillazione atriale cronica. 428
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 368
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome 332
Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan 312
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 312
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. 304
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 302
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 299
Quantitative evaluation of microvessels in Behcet's disease 297
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 295
Effect of two single oral doses of mesoglycan on the coagulative and fibrinolytic system in human. A pharmacodynamic study [Azione di due dosi orali singole di mesoglicano sul sistema coagulativo-fibrinolitico dell'uomo. Studio farmacodinamico] 294
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 294
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 278
Management of an elderly male patient with subconjunctival bleeding associated with pemphigus in the emergency department 270
Cardiac dysautonomia and arterial distensibility in essential hypertensives 268
Takayasu's arteritis: case report of a patient with recurrent subclavian steal syndrome 266
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients 265
Cytokines in acute coronary syndromes 263
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 257
Analisi morfometrica ultrastrutturale di piastrine e leucociti nel paziente sottoposto ad angioplastica coronarica e nell'arteriopatia obliterante periferica 256
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 247
L’apoptosi linfocitaria nell’infarto miocardico acuto senza sopraelevazione del tratto ST 241
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 241
Heart failure and chronic kidney disease in a registry of internal medicine wards 240
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects 239
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 239
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure 236
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 235
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 231
Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion 229
Cardiac papillary fibroelastoma: An unusual source of cerebral embolism solved with local fibrinolysis 229
Chronic urticaria and blastocystis hominis infection. A case report 226
Long-Term use of ticagrelor in patients with prior myocardial infarction 226
Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment 222
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects 221
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 217
Dyslipidemias and fibrinolysis. 217
Different mechanisms of fibrinolysis impairment among dyslipidemic subjects 215
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 213
Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function 211
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 211
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 209
Potenziale endogeno di trombina e parametri di screening della coagulazione. 209
Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study 206
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 206
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 203
Genetic modulation of anti-inflammatory effects of atorvastatin; probably a multi-gene condition 201
Different effect induced by treatment with statins on monocyte tissue factor expression in hypercholesterolemic subjects 201
Structural and functional abnormality of systemic microvessels in cardiac syndrome X 201
Central Retinal Vein Occlusion and Prothrombotic Factors 200
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 198
Circadian rhythm during unfractioned heparin i.v.infusion in man: modification by ASA or pentoxifylline per os 198
Increased TNF-alpha production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine 198
Platelet hyperactivity after statin treatment discontinuation 198
Complement activation in hypercholesterolemia 196
Pharmacogenetics of statins therapy 194
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 194
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 194
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly 192
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 190
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study 190
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study 189
T cell activation and enhanced apoptosis in non-ST elevation myocardi infarction 188
Protective effects of novel metal-nonoates on the cellular components of the vascular system 188
Circulating esRAGE is Associated with a Pro-Inflammatory/Pro-Atherothrombotic Profile in Familial Combined Hyperlipidemia Patients with Non-alcoholic Fatty Liver Disease 188
Time-dependent effect of statins on platelet function in hypercholesterolaemia 187
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 187
In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study 184
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype 184
Genetic influence in statin intolerance 183
Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects 180
Evidences of new risk factors for retinal vein thrombosis 179
Transmitral and pulmonary venous flow study in elite male runners and young adults 179
Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study 178
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 177
Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments 175
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes 173
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia 169
Diatolic filling in hypertrophied hearts of elite runners: an echo-doppler study 169
Microvascular assessment in Behcet disease: videocapillaroscopic study. 169
Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolemic subjects. In vitro effect of cerivastatin 168
Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects 166
Safety of long-term simvastatin discontinuation 165
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 164
Mechanism for antiplatelet action of statins 163
Psoriasis successfully treated with guselkumab in a patient with systemic lupus erythematosus and acquired hemophilia A 163
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards 162
Role of genetic factors in statins side-effects 160
Report of two cases of subconjunctival haemorrhage as first sign of post‐pregnancy acquired haemophilia a (AHA) 159
Variazioni diurne dell'effetto anticoagulante in corso di infusione continua e.v. di eparina non frazionata nell'uomo.Modificazioni indotte da acido acetilsalicilico per os 157
Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling 156
Effetto dell' acido acetilsalicilico e della pentossifillina sulle variazioni diurne dell' attività anticoagulante dell' eparina non frazionata somministrata per infusione continua endovenosa nell' uomo 153
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates -: time for adjuvant therapy in acute coronary syndromes? 151
Refractory Takayasu arteritis successfully treated with infliximab 144
MEDICAL TREATMENT OF CRVO 142
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 141
Relationship between serum complement and different lipid disorders 141
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 140
New generation analysis of thrombin generation in retinal vein thrombosis 133
Totale 21.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.335
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.062 0 0 94 161 70 22 63 36 59 128 122 307
2022/20231.842 112 147 274 234 172 373 33 156 186 30 97 28
2023/20241.531 57 36 123 74 53 464 501 34 16 39 41 93
2024/20252.848 66 142 286 146 372 142 52 147 233 114 336 812
2025/20267.455 529 993 1.018 801 1.363 281 734 198 261 407 215 655
2026/20271.028 321 369 338 0 0 0 0 0 0 0 0 0
Totale 22.648